CMPX: Compass Therapeutics, Inc. Stock

by  •  • Comments Off on CMPX: Compass Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 347.09
Enterprise Value ($M) 303.61
Book Value ($M) 125.23
Book Value / Share 0.91
Price / Book 2.77
NCAV ($M) 117.58
NCAV / Share 0.85
Price / NCAV 2.95

Profitability (mra)
Return on Invested Capital (ROIC) -0.37
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 14.96
Current Ratio 14.96

Balance Sheet (mrq) ($M)
Current Assets 132.75
Assets 140.40
Liabilities 15.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.85
Operating Income -56.62
Net Income -49.38
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -44.85
Cash from Investing 46.77
Cash from Financing 17.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G MPM Oncology Impact Management LP 6.20
02-12 13G/A Adage Capital Partners Gp, L.l.c. 4.36 -39.32
02-04 13G BlackRock, Inc. 5.00
01-16 13G Tang Capital Management Llc 5.40
11-14 13G/A Janus Henderson Group Plc 1.30 -75.90
08-02 13G Blackstone Holdings II L.P. 6.90
03-22 13D/A Orbimed Advisors Llc 13.70 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-13 76,078 407,344 18.68
2025-03-12 303,623 1,084,305 28.00
2025-03-11 227,282 822,932 27.62
2025-03-10 102,398 519,787 19.70

(click for more detail)

Similar Companies
CLDX – Celldex Therapeutics, Inc. CLNN – Clene Inc.
CLRB – Cellectar Biosciences, Inc. CNSP – CNS Pharmaceuticals, Inc.
CNTX – Context Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io